IGF1 and cancer: While pharmacological developments in IGF-I have been oriented towards antagonists, mostly to treat cancer, we used a newly developed IGF-I sensitizer, and observed that age-associated sleep disturbances were ameliorated, with treated old animals showing sleep patterns similar to young ones.